期刊文献+

曲美他嗪对老年慢性心力衰竭患者自主神经功能的影响 被引量:49

Effects of Trimetazidine on Autonomic Nervous Function of Aged Patients with Chronic Heart Failure
下载PDF
导出
摘要 目的探讨曲美他嗪对老年慢性心力衰竭患者自主神经功能的影响。方法将35例老年慢性心力衰竭患者随机分为对照组与曲美他嗪组,所有患者采用心力衰竭常规药物治疗,曲美他嗪组加用曲美他嗪20 mg,3次/d口服,分别于用药前及用药12周检查患者的心脏功能与心率变异性指标。结果两组治疗后均能明显改善慢性心力衰竭患者的心脏射血分数(P<0.05),且曲美他嗪组优于对照组,差异有统计学意义(P<0.05)。两组患者治疗后心率变异性各指标均升高(P<0.05),且曲美他嗪组与对照组比较,差异有统计学意义(P<0.05)。结论曲美他嗪辅助治疗老年心力衰竭疗效显著,能提高心率变异性,改善自主神经功能,无明显不良反应。 Objective To investigate the effects of trimetazidine on the autonomic nervous function in elderly patients with chronic heart failure.Methods 35 elderly patients with heart failure were randomly divided into control group and trimetazidine group.All patients were treated with conventional drug therapy,while trimetazidine group was treated with additional 20 mg trimetazidine three times/day orally.Echocardiography and 24-hour heart rate variability were tested before treatment and 12 weeks after the treatment.Results Ejection fraction of the patients in the trimetazidine group was more significantly increased(P0.05) than the control group(P0.05).The HRV parameters were significantly increased after treatment in the two groups(P0.05),and the trimetazidine group was increased more significantly(P0.05).Conclusion Adding trimetazidine to optimal medical therapy in aged patients with heart failure may improve the autonomic nervous function and increase HRV parameters without any side effects.
出处 《中国全科医学》 CAS CSCD 北大核心 2011年第12期1290-1291,1295,共3页 Chinese General Practice
基金 国家自然科学基金资助项目(30770883)
关键词 曲美他嗪 心力衰竭 心率变异性 Trimetazidine Heart failure Heart rate variability
  • 相关文献

参考文献9

二级参考文献19

  • 1耿春才,邵杉.曲美他嗪治疗急性病毒性心肌炎合并心力衰竭临床疗效观察[J].淮海医药,2007,25(3):203-205. 被引量:9
  • 2Fragsso G, Palloshi A, Puccett. P, et al. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure [J]. J Am Coll Cardiol,2006, 48:992 -998.
  • 3Renee VC, Bertrand M, Xavier B. Beneficial effects of endurance training on cardiac and skeletal muscle energy metabolism in heart failure [J]. Cardiovascular Research, 2007, 73: 10-18.
  • 4Kantor PF, Lucien A, Kozak R, et al. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid xoidation to glucose xoidation by inhabiting mitoehondrial long chain - 3 - ketoacy eoenzyme a thiolase [J]. Cite Ues, 2000, 86: 580-588.
  • 5张琳 鲁大云 刘婧童.曲美他嗪治疗老年缺血性心肌病心力衰竭疗效观察.实用心脑肺血管病杂志,2007,15:201-201.
  • 6王鸣和,王骏.缺血性心肌病的研究近况[J].国际心血管病杂志,2007,34(1):1-5. 被引量:28
  • 7国际心脏病学会和协会及WHO临床命名标准化联合专题组.缺血性心脏病的命名与诊断1979年报告标准.中华心血管杂志,1981,9(1):75-76.
  • 8Depre C,Vanoverschelde JL,Teagtmeyer H.Glucose for the heart[J].Circulation,1999,99(4):578-588.
  • 9Belardineli R.Ischemic heart disease and left ventricular dysfunction:the role of trimetazidine[J].Ital Heart J,2004,(Suppl 2):23s-28s.
  • 10Pornin M,Harpey C,Allal J,et al.Lack of effects of trimetazidine on systemic hemodynamics in patients with coronary artery disease:a placebo-controlled study[J].ClinTrials Metaanal,1994,29(1):49-56.

共引文献110

同被引文献377

引证文献49

二级引证文献459

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部